https://scholars.lib.ntu.edu.tw/handle/123456789/630988
標題: | Guidelines for COVID-19 Laboratory Testing for Emergency Departments From the New Diagnostic Technology Team of the Taiwan Society of Emergency Medicine | 作者: | CHIEN-CHANG LEE Lee, Yi-Tzu CHIH-HUNG WANG Chiu, I-Min Tsai, Weide Lin, Yan-Ren Li, Chih-Huang Hsu, Chin Wang Lai, Pei-Fang Chen, Jiann-Hwa Tsai, Jeffrey Che-Hung Tsai, Shih-Hung How, Chorng-Kuang |
關鍵字: | COVID-19; nucleic acid amplification testing; point-of-care testing; rapid point-of-care molecular testing | 公開日期: | 1-六月-2022 | 卷: | 12 | 期: | 2 | 來源出版物: | Journal of acute medicine | 摘要: | COVID-19 tests have different turnaround times (TATs), accuracy levels, and limitations, which emergency physicians should be aware of. Nucleic acid amplification tests (NAATs) can be divided into standard high throughput tests and rapid molecular diagnostic tests at the point of care (POC). The standard NAAT has the advantages of high throughput and high accuracy with a TAT of 3-4 hours. The POC molecular test has the same advantages of high accuracy as standard high throughput PCR, but can be done in 13-45 minutes. Roche cobas Liat is the most commonly used machine in Taiwan, displaying 99%-100% sensitivity and 100% specificity, respectively. Abbott ID NOW is an isothermal PCR-based POC machine with a sensitivity of 79% and a specificity of 100%. A high rate of false positives and false negatives is associated with rapid antigen testing. Antibody testing is mostly used as part of public health surveys and for testing for immunity. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630988 | ISSN: | 2211-5587 | DOI: | 10.6705/j.jacme.202206_12(2).0001 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。